Recent Finacing
Recent Raise
Rejuvenate Biomed develops combination small-molecule therapeutics for age-related diseases using an AI-driven network-biology in silico platform to identify synergistic repurposed drug combinations; lead candidate RJx-01 targets sarcopenia.
